Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Eiken

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Ugeskrift for Laeger|November 9, 2018
[Multiple vertebral fractures after denosumab discontinuation]Louise Tjelum, Pia Eiken
Maturitas|February 12, 2002
Compliance with 10 years oral hormonal replacement therapyPia Eiken, Niels Kolthoff
Therapeutic Advances in Musculoskeletal Disease|August 20, 2015
Oral bisphosphonates and colon cancer: an updatePia Eiken, Peter Vestergaard
Archives of Internal Medicine|February 16, 2011
Proton pump inhibitor use and the antifracture efficacy of alendronateBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2008
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort studyBo Abrahamsen, Pia Eiken, Richard Eastell
The Journal of Clinical Endocrinology and Metabolism|September 17, 2010
Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysisBo Abrahamsen, Pia Eiken, Richard Eastell
Calcified Tissue International|February 16, 2017
Machine Learning Principles Can Improve Hip Fracture PredictionChristian Kruse, Pia Eiken, Peter Vestergaard
The New England Journal of Medicine|April 24, 2009
More on reports of esophageal cancer with oral bisphosphonate useBo Abrahamsen, Pia Eiken, Richard Eastell
Archives of Osteoporosis|October 3, 2015
Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort studyAnne-Luise Thorsteinsson, Peter Vestergaard, Pia Eiken
Ugeskrift for Laeger|August 7, 2014
[Hormone replacement therapy as primary prevention?]Pia Eiken, Peter Vestergaard, Jens-Erik Jensen
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Ugeskrift for Laeger|November 9, 2018
[Multiple vertebral fractures after denosumab discontinuation]Louise Tjelum, Pia Eiken
Maturitas|February 12, 2002
Compliance with 10 years oral hormonal replacement therapyPia Eiken, Niels Kolthoff
Therapeutic Advances in Musculoskeletal Disease|August 20, 2015
Oral bisphosphonates and colon cancer: an updatePia Eiken, Peter Vestergaard
Archives of Internal Medicine|February 16, 2011
Proton pump inhibitor use and the antifracture efficacy of alendronateBo Abrahamsen, Pia Eiken, Richard Eastell
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2008
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort studyBo Abrahamsen, Pia Eiken, Richard Eastell
The Journal of Clinical Endocrinology and Metabolism|September 17, 2010
Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysisBo Abrahamsen, Pia Eiken, Richard Eastell
Calcified Tissue International|February 16, 2017
Machine Learning Principles Can Improve Hip Fracture PredictionChristian Kruse, Pia Eiken, Peter Vestergaard
The New England Journal of Medicine|April 24, 2009
More on reports of esophageal cancer with oral bisphosphonate useBo Abrahamsen, Pia Eiken, Richard Eastell
Archives of Osteoporosis|October 3, 2015
Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort studyAnne-Luise Thorsteinsson, Peter Vestergaard, Pia Eiken
Ugeskrift for Laeger|August 7, 2014
[Hormone replacement therapy as primary prevention?]Pia Eiken, Peter Vestergaard, Jens-Erik Jensen
Pageof 5